(Q36740217)

16 August 2017

HIV-1 vaccines and adaptive trial designs (English)

1 reference

16 August 2017

11

Anthony S Fauci

1 reference

16 August 2017

5

Barton F Haynes

1 reference

16 August 2017

7

James Kublin

1 reference

16 August 2017

2

Gary J Nabel

1 reference

16 August 2017

9

Giuseppe Pantaleo

1 reference

16 August 2017

8

H Clifford Lane

1 reference

16 August 2017

Lawrence Corey

1

1 reference

16 August 2017

Carl Dieffenbach

3

1 reference

16 August 2017

Peter Gilbert

4

1 reference

16 August 2017

Margaret Johnston

6

1 reference

16 August 2017

Louis J Picker

10

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Science Translational Medicine

16 August 2017

1 reference

16 August 2017

3

1 reference

16 August 2017

79

1 reference

16 August 2017

79ps13

1 reference

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Philosophy of science. The coordinates of truth.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Adaptive clinical trials: progress and challenges

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Issues in the use of adaptive clinical trial designs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

A controlled trial of a human papillomavirus type 16 vaccine

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3616511

HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine

5 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21508308

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1126/SCITRANSLMED.3001863

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

21508308

1 reference